Meeting
2018 ASCO Annual Meeting
Total neoadjuvant treatment versus chemoradiotherapy in locally advanced rectal cancer: A propensity score analysis from two prospective phase II clinical trials.
Authors
Jianwei Zhang
Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
Jianwei Zhang , Huabin Hu , Yue Cai , Dianke Chen , Jian Xiao , Jiayu Ling , Yanhong Deng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3600)
DOI
10.1200/JCO.2018.36.15_suppl.3600
Abstract #
3600
Poster Bd #
93
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Totally neoadjuvant chemoradiation therapy with mFOLFOX6 in locally advanced rectal cancer: A single-arm phase II study (FOTAC).
First Author: Yanhong Deng
Poster
2016 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.
First Author: Yanhong Deng
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao